Don Wright, MD, MPH
Acting Director, ORI
Acting Director, Office of Research Integrity
Deputy Assistant Secretary for Health
Director, Office of Disease Prevention and Health Promotion
U.S. Department of Health and Human Services
Dr. Don Wright, Acting Director of the Office of Research Integrity, is also the Deputy Assistant Secretary for Health and Director of the Office of Disease Prevention and Health Promotion (ODPHP), where he leads coordination and policy development for public health and prevention activities and the nation’s Healthy People initiative within the Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services.
Dr. Wright also served as the Acting Director of the Office of Research Integrity from 2009 to 2012. Between 2007 and 2009, Dr. Wright was the Principal Deputy Assistant Secretary for Health where he managed 12 public health program offices and the Commissioned Corps of the U.S. Public Health Service. He was also appointed by the President to serve as the alternate U.S. delegate to the World Health Organization Executive Board. From 2003 to 2007, Dr. Wright was the Director of the Office of Occupational Medicine with the Occupational Safety and Health Administration within the U.S. Department of Labor where he built strong governmental and non-governmental partnerships addressing safety and health.
Dr. Wright received his undergraduate degree from Texas Tech University, a medical degree from the University of Texas, and an MPH from the Medical College of Wisconsin. He completed his family medicine residency training at Baylor College of Medicine and is board-certified in both Family Medicine and Preventive Medicine. He is a fellow of the American College of Occupational and Environmental Medicine and the American Academy of Family Physicians.
Dr. Dahlberg is the Deputy Director of the Office of Research Integrity. He received a B.A. from Brandeis University in 1963 and a Ph.D. in in microbiology from Purdue University in 1968. After post-doctoral fellowships at the Public Health Research Institute of the City of New York and at Rutgers University, he spent sixteen years at the National Cancer Institute in Bethesda carrying out research on retroviruses with an initial emphasis on ultrastructure and virus classification. Subsequently he focused increasingly on immunoassay development and molecular biology and, using all of these technologies, began research on lentiviruses in 1980. In 1988, Dr. Dahlberg joined a small biotechnology company as director of research and development, where he developed procedures for growing macrophage cells in serum-free medium and using them to test drugs for their ability to inhibit HIV replication. Dr. Dahlberg joined the Office of Scientific Integrity in 1992, just prior to its being reorganized into ORI. While at ORI, he has developed a variety of computer-aided techniques to assist in analysis of data and detection of evidence of data falsification. Previously, Dr. Dahlberg was the Director of the Division of Investigative Oversight.
Susan Garfinkel, Ph.D., joined ORI in 2003 as a Scientist-Investigator and is currently the Director for the Division of Investigative Oversight (DIO). Previously, she worked at the American Health Assistance Foundation where she served as Director of Research Grants. Prior to that she managed the Lung Cell and Vascular Biology Research Program at NHLBI, NIH; served as science advisor at the Einstein Institute for Science, Health and the Courts; served as Chair for the Public Education Committee of the International Society for Stem Cell Research; worked as an associate investigator at the Center for Molecular Medicine, Maine Medical Center Research Institute, and as a researcher in the Jerome H. Holland Laboratory, Department of Molecular Biology, American Red Cross. She received her doctorate in genetics from George Washington University and did postdoctoral training in the Holland Laboratory. She earned a bachelor’s degree in biology at SUNY-Binghamton.
Ms. Zoë Hammatt served as Director of the Research Integrity Program and as the Research Integrity Officer at the University of Hawaii. A licensed attorney with a Master's degree in Law and Ethics, Ms. Hammatt served on the faculty at the University of Hawaii medical and law schools and taught courses in biomedical ethics, regulatory compliance, human subjects protection, and responsible conduct of research. She also has served as the Legal and Regulatory Specialist and Chair of the Ethics and Regulatory Subcommittee for the NIH-funded Research Centers in Minority Institutions (RCMI) Translational Research Network (RTRN), a national consortium of 18 institutions dedicated to reducing health disparities through collaborative basic, clinical, and translational research. Among her many accomplishments, she led the harmonization of the IRB process across all 18 RCMI institutions. Ms. Hammatt has been a Fellow with the St. Francis International Center for Healthcare Ethics in Honolulu since 1997 and since 1995 has been involved in international projects to empower women in Central and East Europe as they develop initiatives that support their communities.
Ms. Hammatt received a B.A. in English Literature at Loyola Marymount University in Los Angeles, a Master's degree in Law and Ethics in Medicine from the University of Glasgow in Scotland, and a J.D. from the University of Hawaii, where she practiced law with Case Lombardi and Pettit, the oldest law firm in Hawaii.